School of Medicine

Listed below are this month’s featured news stories. • Breaking down Alzheimer’s (week of Nov. 1) • Preventing transplant rejection (week of Nov. 8) • Predicting glaucoma (week of Nov. 15) • No-incision stomach stapling (week of Nov. 22) • Organ donor health (week of Nov. 29)

School of Medicine investigators have developed a model to identify patients at high risk of developing glaucoma.

School of Medicine researchers found that a malaria drug eased many symptoms of metabolic syndrome in mice. Study findings were published in the November issue of Cell Metabolism, and senior author Clay F. Semenkovich, M.D., professor of medicine and of cell biology and physiology, says funding for a clinical trial has been received.

Results from School of Medicine research suggest that a drug could save millions in health-care costs by preventing immune attacks following kidney transplants.

Photo by Tim ParkerThe Corpus Delicti: Just Desserts play analyzes the ethics of dissection using a life-sized cadaver from gelatin with fruits and vegetables for organs.

F. Sessions Cole, M.D., has been named assistant vice chancellor for children’s health at the School of Medicine.

Investigators at the School of Medicine have developed a model to identify patients at high risk of developing glaucoma. Their research was presented at the annual meeting of the American Academy of Ophthalmology in Las Vegas.

Three Alzheimer’s disease researchers at the School of Medicine in have been named to the 2006 Scientific American 50, an honorary list of the year’s “prime movers” in a variety of scientific disciplines.

ColeF. Sessions Cole, M.D., has been appointed assistant vice chancellor for children’s health at the School of Medicine and chief medical officer at St. Louis Children’s Hospital.

School of Medicine researchers find a potential therapeutic regimen for patients with aggressive neuroendocrine tumors.